Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
JD HEALTH
06618
5
ALI HEALTH
00241
| (FY)Dec 31, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 35.53%16.59B | 47.21%3.95B | 44.18%4.07B | 27.03%12.24B | 52.93%4.01B | 15.20%2.73B | 18.67%2.69B | 18.22%2.82B | 30.67%9.64B | 27.87%2.62B |
| Cost of revenue | 34.13%10.69B | 48.56%2.59B | 43.38%2.62B | 24.07%7.97B | 48.17%2.59B | 12.79%1.81B | 15.67%1.74B | 16.76%1.83B | 35.28%6.42B | 31.93%1.75B |
| Gross profit | 38.18%5.9B | 44.67%1.37B | 45.71%1.44B | 32.92%4.27B | 62.35%1.42B | 20.27%916.25M | 24.75%947M | 20.89%991M | 22.34%3.21B | 20.44%873.29M |
| Operating expense | 34.69%4.8B | 53.96%1.32B | 58.77%1.09B | 31.24%3.56B | 56.63%1.25B | 11.72%767.03M | 27.53%858M | 23.33%684M | 33.83%2.71B | 40.18%798.7M |
| Operating profit | 55.62%1.11B | -44.94%49M | 16.61%358M | 41.99%712M | 123.59%166.78M | 98.19%149.22M | 3.04%89M | 15.77%307M | -16.46%501.43M | -51.98%74.59M |
| Net non-operating interest income (expenses) | -278.57%-53M | -12M | -1,100.00%-12M | -46.24%-14M | -191.35%-10M | 12.20%-3M | 0 | 28.72%-1M | -57.35%-9.57M | -144.97%-3.43M |
| Non-operating interest income | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -35.00%13K | --0 |
| Non-operating interest expense | 278.57%53M | --12M | 1,100.00%12M | 180.11%14M | 840.21%9.99M | 150.42%3.02M | --0 | -29.03%1M | -18.12%5M | -24.20%1.06M |
| Total other finance cost | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --4.59M | --2.37M |
| Net investment income | 544.08%1.35M | 408.11%228K | ||||||||
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | -176M | 0 | ||||||||
| Income from associates and other participating interests | -222.22%-55M | -94.12%2M | -64.71%6M | 1,292.05%45M | 702.28%22.74M | -28.74M | 34M | 17M | 79.57%-3.78M | -3.78M |
| Special income (charges) | 567M | 0 | 99.99%-16K | -1,069.27%-143.54M | -1,056.46%-143.57M | |||||
| Less:Other special charges | ---567M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 1,142.20%3.61M | 1,858.94%3.64M |
| Less:Write off | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 1,008.64%139.93M | ---- |
| Other non-operating income (expenses) | 1,320.00%71M | 350.00%9M | 92.31%25M | 7,475.76%5M | -565.09%-9.94M | 90.15%-61K | 2,400.00%2M | 948.56%13M | -98.37%66K | 79.73%2.14M |
| Income before tax | 95.05%1.46B | -62.10%47M | 11.54%377M | 116.21%748M | 327.38%167.87M | 66.18%118.14M | 43.16%124M | 28.97%338M | -37.77%345.96M | -151.76%-73.83M |
| Income tax | 61.06%488M | -88.89%4M | -37.04%68M | 178.91%303M | 382.58%92.11M | 83.17%66.89M | 33.07%36M | 39.06%108M | -36.14%108.64M | -294.44%-32.6M |
| Net income | 118.47%970M | -49.43%44M | 33.91%308M | 87.09%444M | 281.31%74.75M | 51.14%52.25M | 46.07%87M | 24.72%230M | -38.49%237.32M | -132.76%-41.23M |
| Net income continuous operations | 118.20%971M | -51.14%43M | 34.35%309M | 87.51%445M | 283.74%75.75M | 48.24%51.25M | 47.74%88M | 24.72%230M | -38.49%237.32M | -132.76%-41.23M |
| Noncontrolling interests | 77.78%-2M | -4M | 2M | -290.19%-9M | -80,081.82%-8.8M | -133.95%-202K | 0 | 0 | 282.63%4.73M | -90.76%11K |
| Net income attributable to the company | 114.32%973M | -50.57%43M | 35.81%311M | 95.20%454M | 305.02%84.55M | 57.33%53.45M | 47.08%87M | 26.73%229M | -40.12%232.58M | -132.80%-41.24M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | 114.32%973M | -50.57%43M | 35.81%311M | 95.20%454M | 305.02%84.55M | 57.33%53.45M | 47.08%87M | 26.73%229M | -40.12%232.58M | -132.80%-41.24M |
| Gross dividend payment | ||||||||||
| Basic earnings per share | 114.72%216.44 | -49.25%9.82 | 35.69%69.23 | 82.11%100.8 | 273.16%18.84 | 38.47%11.59 | 31.19%19.35 | 18.35%51.02 | -40.64%55.35 | -136.35%-10.88 |
| Diluted earnings per share | 117.81%212.82 | -48.35%9.71 | 37.37%67.78 | 84.12%97.71 | 268.75%18.36 | 40.30%11.21 | 33.90%18.8 | 19.18%49.34 | -39.39%53.07 | -138.30%-10.88 |
| Dividend per share | 30 | |||||||||
| Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |